Patient‐level meta‐analysis of the EDITION 1, 2 and 3 studies: glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus glargine 100 U/ml in people with type 2 diabetes-Reference-Cited by-同舟云学术

Patient‐level meta‐analysis of the EDITION 1, 2 and 3 studies: glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus glargine 100 U/ml in people with type 2 diabetes

Published:2015-06-16 Issue:9 Volume:17 Page:859-867
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Ritzel R.¹,Roussel R.²³⁴,Bolli G. B.⁵,Vinet L.⁶,Brulle‐Wohlhueter C.⁷,Glezer S.⁷,Yki‐Järvinen H.⁸

Affiliation:

1. Klinikum Schwabing, Städtisches Klinikum München GmbH Munich Germany

2. Diabetology Endocrinology Nutrition DHU FIRE, Bichat Hospital, Assistance Publique Hôpitaux de Paris Paris France

3. INSERM U1138, Centre de Recherche des Cordeliers Paris France

4. UFR de Médecine Université Paris Diderot, Sorbonne Paris Cité Paris France

5. Department of Medicine University of Perugia Perugia Italy

6. EXPERIS IT Nanterre France

7. Sanofi Paris France

8. Division of Diabetes Faculty of Medicine and Helsinki University Central Hospital, University of Helsinki Helsinki Finland

Funder

Sanofi

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.12485

Reference19 articles.

1. The Past 200 Years in Diabetes

2. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach

3. Three-Year Efficacy of Complex Insulin Regimens in Type 2 Diabetes

4. New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 2 Diabetes Using Basal and Mealtime Insulin: Glucose Control and Hypoglycemia in a 6-Month Randomized Controlled Trial (EDITION 1)

5. New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 2 Diabetes Using Oral Agents and Basal Insulin: Glucose Control and Hypoglycemia in a 6-Month Randomized Controlled Trial (EDITION 2)

Cited by 200 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of insulin glargine 300 U/mL in people with type 2 diabetes in China: The INITIATION study;Diabetes, Obesity and Metabolism;2024-07-29

2. A dose titration protocol for once‐daily insulin glargine 300 U/mL for the treatment of diabetes mellitus in dogs;Journal of Veterinary Internal Medicine;2024-06-03

3. Real-world effectiveness of iGlarLixi in individuals with T2D sub-optimally controlled on oral anti-diabetic drugs with or without basal insulin in daily practice in Saudi Arabia (EMPOWER study);Endocrine and Metabolic Science;2024-06

4. Insulin therapy in type 2 diabetes: Insights into clinical efficacy, patient-reported outcomes, and adherence challenges;World Journal of Diabetes;2024-05-15

5. Once-weekly insulins: a promising approach to reduce the treatment burden in people with diabetes;Diabetologia;2024-04-29